文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Nanoparticles for hematologic diseases detection and treatment.

作者信息

Limongi Tania, Susa Francesca, Cauda Valentina

机构信息

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy.

出版信息

Hematol Med Oncol. 2019 Jun 28;4:1000183. doi: 10.15761/hmo.1000183.


DOI:10.15761/hmo.1000183
PMID:33860108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7610588/
Abstract

Nanotechnology, as an interdisciplinary science, combines engineering, physics, material sciences, and chemistry with the biomedicine knowhow, trying the management of a wide range of diseases. Nanoparticle-based devices holding tumor imaging, targeting and therapy capabilities are formerly under study. Since conventional hematological therapies are sometimes defined by reduced selectivity, low therapeutic efficacy and many side effects, in this review we discuss the potential advantages of the NPs' use in alternative/combined strategies. In the introduction the basic notion of nanomedicine and nanoparticles' classification are described, while in the main text nanodiagnostics, nanotherapeutics and theranostics solutions coming out from the use of a wide-ranging NPs availability are listed and discussed.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/7610588/0f3eccb2abe7/EMS121177-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/7610588/0b81f02fa555/EMS121177-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/7610588/0f3eccb2abe7/EMS121177-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/7610588/0b81f02fa555/EMS121177-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/7610588/0f3eccb2abe7/EMS121177-f002.jpg

相似文献

[1]
Nanoparticles for hematologic diseases detection and treatment.

Hematol Med Oncol. 2019-6-28

[2]
Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.

Semin Cancer Biol. 2021-2

[3]
Nanomedicine in veterinary oncology.

Vet J. 2015-8

[4]
Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.

Front Bioeng Biotechnol. 2017-12-18

[5]
Advancing Nanomedicine Through Electron Microscopy: Insights Into Nanoparticle Cellular Interactions and Biomedical Applications.

Int J Nanomedicine. 2025-3-8

[6]
Broad-Spectrum Theranostics and Biomedical Application of Functionalized Nanomaterials.

Polymers (Basel). 2022-3-17

[7]
Nanotechnology in Hematology: Enhancing Therapeutic Efficacy With Nanoparticles.

Health Sci Rep. 2025-5-19

[8]
Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation.

ACS Nano. 2023-8-8

[9]
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.

Curr Med Chem. 2018

[10]
All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.

Small. 2021-12

引用本文的文献

[1]
Nanotechnology in Hematology: Enhancing Therapeutic Efficacy With Nanoparticles.

Health Sci Rep. 2025-5-19

[2]
Computational Frontiers in Aptamer-Based Nanomedicine for Precision Therapeutics: A Comprehensive Review.

ACS Omega. 2024-6-10

[3]
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology.

Eur J Med Res. 2024-4-9

[4]
Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia.

ADMET DMPK. 2023-9-26

[5]
Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies.

Nanoscale Adv. 2023-1-11

[6]
Special Issue "Metal and Metal Oxide Nanoparticles: Design, Characterization, and Biomedical Applications".

Materials (Basel). 2021-11-28

本文引用的文献

[1]
Pepsin Assisted Doxorubicin Delivery from Mesoporous Silica Nanoparticles Downsizes Solid Tumor Volume and Enhances Therapeutic Efficacy in Experimental Murine Lymphoma.

ACS Appl Bio Mater. 2018-12-17

[2]
Nanoporous silica coupled MALDI-TOF MS detection of Bence-Jones proteins in human urine for diagnosis of multiple myeloma.

Talanta. 2019-3-16

[3]
In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.

Int J Nanomedicine. 2019-3-27

[4]
Remote Magnetic Control of Autophagy in Mouse B-Lymphoma Cells with Iron Oxide Nanoparticles.

Nanomaterials (Basel). 2019-4-4

[5]
Nanomaterial Exposure Induced Neutrophil Extracellular Traps: A New Target in Inflammation and Innate Immunity.

J Immunol Res. 2019-2-28

[6]
Emerging Nano-/Microapproaches for Cancer Immunotherapy.

Adv Sci (Weinh). 2019-1-13

[7]
Carbon-Based Nanomaterials for Biomedical Applications: A Recent Study.

Front Pharmacol. 2019-3-11

[8]
Nano-based approach to combat emerging viral (NIPAH virus) infection.

Nanomedicine. 2019-3-21

[9]
Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach.

Nanomedicine (Lond). 2019-3-22

[10]
Improving dispersal of therapeutic nanoparticles in the human body.

Nanomedicine (Lond). 2019-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索